Piedmont Healthcare Enrolling Patients in Two COVID-19-Related Clinical Trials
May 06, 2020
May 06, 2020
ATLANTA, Georgia, May 6 -- Piedmont Healthcare issued the following news release:
Piedmont Healthcare will participate in two new clinical trials that will investigate therapies for patients who are positive for COVID-19: one that will evaluate the efficacy of the anti-inflammatory drug Gimsilumab and another that will investigate proning, or repositioning patients to improve their oxygen levels. These studies began enrolling patients in early May.
The studies are offic . . .
Piedmont Healthcare will participate in two new clinical trials that will investigate therapies for patients who are positive for COVID-19: one that will evaluate the efficacy of the anti-inflammatory drug Gimsilumab and another that will investigate proning, or repositioning patients to improve their oxygen levels. These studies began enrolling patients in early May.
The studies are offic . . .